June 8th 2025
A continuous biomanufacturing platform can process higher/lower quantities of a drug as needed and allow manufacturers to respond to changing markets.
March 7th 2025
RNA modalities will especially benefit from fuller adoption of continuous manufacturing platforms.
June 8th 2024
The biopharma industry is looking at continuous chromatography for sensitive molecules.
November 1st 2023
Sara Fathollahi, PhD, product application specialist at DFE Pharma, makes the case of how excipient suppliers can support the transition from batch to continuous manufacturing.
Sara Fathollahi, PhD, product application specialist at DFE Pharma, discusses a major challenge in the adoption of continuous manufacturing.